| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $73K | +23.7% |
| R&D Expense | $11.3M | +60.6% |
| SG&A Expense | $6.6M | +2.1% |
| Operating Income | -$17.9M | -31.3% |
| Net Income | -$18.2M | -31.2% |
| EPS (Basic) | -$2.23 | +31.0% |
| EPS (Diluted) | -$2.23 | +31.0% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.1M | -79.5% |
| Accounts Receivable | $3K | -88.0% |
| Current Assets | $4.8M | -76.6% |
| Total Assets | $6.0M | -72.1% |
| Current Liabilities | $2.5M | +85.0% |
| Total Liabilities | $3.1M | +125.8% |
| Stockholders' Equity | $2.9M | -85.6% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.9M | -23.9% |
| Capital Expenditures | $13K | -94.1% |
| Investing Cash Flow | -$13K | +94.1% |
| Financing Cash Flow | $22.5M | +0.0% |
| Free Cash Flow | -$15.9M | -21.9% |